ABDX
NEUTRALAbingdon Health Announces Directorate Changes
The healthcare company announces changes to its leadership team, including the appointment of a new Non-Executive Director.
Abingdon Health
5.75GBX
0.00%
Market Cap
10.90M
Volume
1k
1% of avg
P/E Ratio
1.44
EPS (TTM)
0.04
Beta
0.2
Day Range
0.00p - 0.00p
52 Week Range
0.00p5.75p11.75p
5.75p
Upcoming Events
ABDX
BADAbingdon Health Reports Widening Losses Despite Revenue Growth in Half-Year Results
The diagnostics firm reported increased revenue but widening losses in its half-year results. Despite new contracts and market expansion, core segment revenue declined and profitability remains a distant goal, with ongoing market challenges and execution risks.
ABDX
NEUTRALAbingdon Health Plc Provides Notice of Results
The healthcare diagnostics company has announced it will release its interim results and host an investor presentation in the coming weeks.
ABDX
NEUTRALAbingdon Health to Launch Innovative Saliva-Based Pregnancy Test in Germany
The healthcare company is expanding the distribution of its innovative saliva-based pregnancy test to Germany and other European markets.
ABDX
GOODAbingdon Health Awarded Funding for Malaria Diagnostic Test Development
The healthcare company has been awarded funding to develop a rapid diagnostic test for malaria, in partnership with leading research institutions. This new test aims to improve malaria control efforts in sub-Saharan Africa.
ABDX
GOODAbingdon Health wins major diagnostics contract
The diagnostics company has won a major contract worth over £500k, showcasing its expanded service capabilities following a recent acquisition.
ABDX
NEUTRALAbingdon Health Appoints New CFO to Support Growth
Appointment of experienced CFO to support growth plans of this med-tech contract service provider.
ABDX
GOODAbingdon Health opens new analytical laboratory in Doncaster
The diagnostics company has opened a new analytical laboratory in Doncaster, strengthening its contract development and manufacturing services for the lateral flow testing market and adjacent sectors.
ABDX
GOODAbingdon Health secures $2 million contract for sexually transmitted disease tests
The diagnostics company has secured a major contract worth up to $2 million to develop and gain regulatory approval for four sexually transmitted disease tests, leveraging its expertise in development, manufacturing, and regulatory services.
ABDX
NEUTRALAbingdon Health Expects Continued Revenue Growth
The diagnostics and research company provides a positive trading update, expecting continued revenue growth, but notes near-term uncertainty around new contract wins.